SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-011047
Filing Date
2023-03-31
Accepted
2023-03-30 17:38:04
Documents
84
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cala-20221231.htm   iXBRL 10-K 4639151
2 EX-31.1 cala-ex31_1.htm EX-31 16740
3 EX-31.2 cala-ex31_2.htm EX-31 16696
4 EX-32.1 cala-ex32_1.htm EX-32 11449
5 EX-32.2 cala-ex32_2.htm EX-32 11445
  Complete submission text file 0000950170-23-011047.txt   14987435

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cala-20221231.xsd EX-101.SCH 82430
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cala-20221231_lab.xml EX-101.LAB 675423
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cala-20221231_pre.xml EX-101.PRE 531619
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cala-20221231_def.xml EX-101.DEF 321640
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cala-20221231_cal.xml EX-101.CAL 61426
78 EXTRACTED XBRL INSTANCE DOCUMENT cala-20221231_htm.xml XML 2937882
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36644 | Film No.: 23781995
SIC: 2834 Pharmaceutical Preparations